Doctolib
Indexed for the AI capabilities inside the Doctolib platform rather than for the platform itself, which is context under this index's product scoping rule, and the first non US vendor treated this way. Doctolib is the dominant digital health infrastructure provider across France, Germany, and Italy, spanning appointment booking, practice management, and clinical records. Its ambient documentation capability, the Consultation Assistant, is built on technology from the June 2024 acquisition of Typeless, an EPFL and Idiap Research Institute spin off specializing in AI speech recognition, and uses large language models to convert spoken doctor patient dialogue into structured medical text including clinical notes and doctor letters. In November 2025 the company launched an all in one practice management product incorporating three AI assistants, including a telephone assistant that answers calls around the clock, categorizes inquiries, and transfers appointment bookings directly into the Doctolib system; the company reports practices can save up to ten hours per week on administrative tasks. That product launched for general practitioners, pediatricians, and gynecologists with additional specialties planned. The strategic significance is distribution: ambient documentation delivered inside the appointment and record workflow a practice already uses, which is a different competitive position from standalone scribes such as Nabla or Abridge. Note that European regulators treat ambient scribes as software as a medical device, with the UK MHRA classifying them accordingly, so regulatory posture differs from the US market.
Capability Axes
The sixth product scoped platform vendor in this index and the first outside the US. What a practice buys is Doctolib: booking, practice management, and patient records across France, Germany, and Italy. The Consultation Assistant and the practice management AI assistants are capabilities layered onto that platform, and the ambient documentation technology itself was acquired rather than built, coming from the June 2024 purchase of Typeless. No practice selects Doctolib for the AI.
Provenance of the core speech technology is unusually traceable: it came from Typeless, a spin off of EPFL and the Idiap Research Institute specializing in speech recognition, acquired June 2024, and the documentation capability is described as large language model based. Naming the acquired research lineage lets a buyer assess where the capability actually originates rather than accepting a generic AI claim. Held back from A because no model detail, accuracy measurement, or validation methodology was retrieved for the deployed assistants.
Distribution is the whole argument and it is structural rather than a partnership. Because Doctolib already operates the appointment system, practice management, and record for a large share of practices in its markets, ambient documentation arrives inside the workflow rather than beside it, and the telephone assistant transfers bookings directly into the same system. A standalone scribe must integrate to reach that position; Doctolib starts there. That advantage is confined to its own installed base, which is the correct caveat.
No public pricing retrieved for the AI capabilities. The company reports practices can save up to ten hours per week on administrative tasks with the AI enabled practice software, which is a vendor stated efficiency claim rather than a price. Establish whether the Consultation Assistant and the AI assistants carry incremental cost above existing Doctolib subscription, the standard question for platform vendors indexed under the scope rule here.
The platform is broad but the AI practice management product is not yet: it launched in November 2025 for general practitioners, pediatricians, and gynecologists, with further specialties stated as planned. Buyers outside those three specialties should confirm current availability rather than assume platform level coverage extends to the AI assistants. Geographic scope is France, Germany, and Italy.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Contact the vendor
|
Platform subscription; AI capability pricing not disclosed | — | — | Vendor Published |
No public pricing retrieved for the AI capabilities specifically. As with the other platform vendors indexed under this index's product scoping rule, the decisive question is whether ambient documentation and the practice management AI assistants are included in existing Doctolib subscription or carry incremental cost, since a bundled capability compares very differently against a separately priced standalone scribe. Practices should also confirm availability for their specialty: the AI practice software launched for general practice, pediatrics, and gynecology only.